Spartan Bioscience files for creditor protection after identifying 'issue' with COVID-19 test

OBIO News
Written By Viktoriya Shabat
Spartan-Logo_1000x253.png

The Ottawa-based company that developed a rapid COVID-19 testing device says it has filed for creditor protection after finding an undisclosed problem with the technology. Spartan Bioscience's interim CEO Jennifer Ross-Carriere said through a spokesperson Tuesday that the company has paused shipments of its COVID-19 testing cube while it works to resolve the "recently-identified issue."

Viktoriya Shabat
Previous

Dialogue Closes TSX IPO, Raising $100 Million
Next

PlantForm signs agreement with Bio-Manguinhos/Fiocruz to develop a biosimilar pembrolizumab cancer dru